The Enterprise Value as of December 2024 (TTM) for Histogen Inc. (HSTO) is -4487565.00

According to Histogen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -4487565.00. This represents a change of 163.44% compared to the average of -1703431.47 of the last 4 quarters.

Histogen Inc. (HSTO) Historical Enterprise Value (quarterly & annually)

How has HSTO Enterprise Value performed in the past?

The mean historical Enterprise Value of Histogen Inc. over the last ten years is 4.21B. The current -4487565.00 Enterprise Value has changed -110.65% with respect to the historical average. Over the past ten years (40 quarters), HSTO's Enterprise Value was at its highest in in the March 2018 quarter at 35.27B. The Enterprise Value was at its lowest in in the September 2022 quarter at -5068258.95.

Histogen Inc. (HSTO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Histogen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Histogen Inc. (HSTO) Average Enterprise Value

How has HSTO Enterprise Value performed in the past?

The current Enterprise Value of Histogen Inc. (HSTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Histogen Inc. (HSTO) Enterprise Value vs. Peers

How is HSTO’s Enterprise Value compared to its peers?

Histogen Inc.’s Enterprise Value is less than Virax Biolabs Group Limited (3.80M), less than Baudax Bio, Inc. (0), less than YS Biopharma Co., Ltd. (764.28M), less than NexImmune, Inc. (-2118679.00), less than Altamira Therapeutics Ltd. (503.61K), less than Aileron Therapeutics, Inc. (31.10M), less than Artelo Biosciences, Inc. (523.87K), less than Curis, Inc. (9.67M), greater than Timber Pharmaceuticals, Inc. (-7573217.00), less than SAB Biotherapeutics, Inc. (33.69M), less than Senti Biosciences, Inc. (43.27M), less than Cingulate Inc. (5.77M), greater than Bellicum Pharmaceuticals, Inc. (-5130674.00), less than Hillstream BioPharma, Inc. (1.48M), greater than TRACON Pharmaceuticals, Inc. (-6160275.00), less than Entera Bio Ltd. (70.37M), less than Tempest Therapeutics, Inc. (33.86M), less than Better Therapeutics, Inc. (7.71M), less than Sonnet BioTherapeutics Holdings, Inc. (4.31M), less than Palisade Bio, Inc. (-2960089.00), less than Bright Minds Biosciences Inc. (369.25M), less than Tonix Pharmaceuticals Holding Corp. (50.23M),

Build a custom stock screener for Histogen Inc. (HSTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Histogen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Histogen Inc. (HSTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Histogen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.